PBT434

Manufacturer	DCChemicals
Category	Reagents & Chemicals Molecules
Type	Chemicals
Specific against	other
Amount	1 g
Item no.	DCC-DC22191-1g
CASRN	1232841-78-9
eClass 6.1	32160000
eClass 9.0	32160000
Available
Field of Application	PBT434 is a novel quinazolinone compound with effect of lowering cellular iron levels, prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson disease; inhibits iron-mediated redox activity and iron-mediated aggr
Molecule Weight	383, 067

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 g

available

Delivery expected until 6/20/2024